<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">rpcardio</journal-id><journal-title-group><journal-title xml:lang="en">Rational Pharmacotherapy in Cardiology</journal-title><trans-title-group xml:lang="ru"><trans-title>Рациональная Фармакотерапия в Кардиологии</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1819-6446</issn><issn pub-type="epub">2225-3653</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20996/1819-6446-2015-11-5-522-528</article-id><article-id custom-type="elpub" pub-id-type="custom">rpcardio-327</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>POINT OF VIEW</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ТОЧКА ЗРЕНИЯ</subject></subj-group></article-categories><title-group><article-title>The role of peptide hormones (adiponectin, leptin, insulin) in the pathogenesis of atherosclerosis</article-title><trans-title-group xml:lang="ru"><trans-title>РОЛЬ ПЕПТИДНЫХ ГОРМОНОВ (АДИПОНЕКТИН, ЛЕПТИН, ИНСУЛИН) В ПАТОГЕНЕЗЕ АТЕРОСКЛЕРОЗА</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сметнев</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Smetnev</surname><given-names>S. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кардиолог, аспирант лаборатории молекулярной генетики ГНИЦ ПМ </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мешков</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Meshkov</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., руководитель лаборатории молекулярной генетики ГНИЦ ПМ</p></bio><email xlink:type="simple">meshkov@lipidclinic.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Государственный научно-исследовательский центр профилактической медицины 101000, Москва, Петроверигский пер., 10</institution><country>Россия</country></aff><aff xml:lang="en"><institution>State Research Centre for Preventive Medicine. Petroverigsky per. 10, Moscow, 101990 Russia</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2015</year></pub-date><pub-date pub-type="epub"><day>05</day><month>11</month><year>2015</year></pub-date><volume>11</volume><issue>5</issue><fpage>522</fpage><lpage>528</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Smetnev S.A., Meshkov A.N., 2015</copyright-statement><copyright-year>2015</copyright-year><copyright-holder xml:lang="ru">Сметнев С.А., Мешков А.Н.</copyright-holder><copyright-holder xml:lang="en">Smetnev S.A., Meshkov A.N.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.rpcardio.online/jour/article/view/327">https://www.rpcardio.online/jour/article/view/327</self-uri><abstract><p>Currently, cardiovascular diseases (CVD) remain the main problem in the world and in Russia in particular. The study of the causes and progression of atherosclerosis is a critical moment in the fight against CVD. Adipose tissue and processes that occur in it attracts attention in recent years. The important role of adipose tissue as an endocrine and immune organ is revealed as well as its participation in the development of the inflammatory process. This leads to the development of initial manifestations of atherosclerosis a precursor of many metabolic disorders and CVD. Particular attention causes adipokines regulatory peptide hormones in the adipose tissue, as well as insulin, due to its close relationship with the adipose tissue and especially with adiponectin and leptin. Recent data on the role of adiponectin, leptin and insulin in the pathogenesis of atherosclerosis in order to identify new potential targets among peptide hormones for the treatment of atherosclerosis are presented. </p></abstract><trans-abstract xml:lang="ru"><p>В настоящее время сердечно-сосудистые заболевания (ССЗ) остаются основной проблемой в мире и в России, в частности. Изучение причин возникновения и прогрессирования атеросклероза является критически важным моментом в борьбе с ССЗ. В последнее время все большее внимание привлекает жировая ткань, и те процессы, которые происходят в ней. Выявлена важная роль жировой ткани как иммунного и эндокринного органа, и её большое участие в развитии воспалительного процесса. Последний приводит к развитию начальных проявлений атеросклероза – предшественника многих метаболических нарушений и ССЗ. Особое значение имеют адипокины – пептидные регуляторные гормоны, являющиеся компонентами жировой ткани, и инсулин, в связи с его тесным взаимодействием с жировой тканью и, особенно, с адипонектином и лептином. Представлены современные данные о роли адипонектина, лептина и инсулина в патогенезе атеросклероза с целью выявления новых потенциальных мишеней для лечения атеросклероза среди пептидных гормонов. </p></trans-abstract><kwd-group xml:lang="ru"><kwd>регуляторные пептиды</kwd><kwd>адипонектин</kwd><kwd>лептин</kwd><kwd>инсулин</kwd><kwd>сердечно-сосудистые заболевания</kwd><kwd>жировая ткань</kwd></kwd-group><kwd-group xml:lang="en"><kwd>regulatory peptides</kwd><kwd>adiponectin</kwd><kwd>leptin</kwd><kwd>insulin</kwd><kwd>cardiovascular diseases</kwd><kwd>fatty tissue</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Mathers C.D., Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3:e442.</mixed-citation><mixed-citation xml:lang="en">Mathers C.D., Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3:e442.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Yevseyev ME, Dzhanibekova AR, Eremin MV, et al. Approaches to the assessment of cardiovascular risk in young adults. Profilakticheskaya Meditsina 2011; 5: 7-11. In Russian (Евсеева М. Е., Джанибекова А. Р., Еремин М. В. и др. Подходы к оценке сердечно-сосудистого риска у лиц молодого возраста. Профилактическая Медицина 2011;5:7-11).</mixed-citation><mixed-citation xml:lang="en">Yevseyev ME, Dzhanibekova AR, Eremin MV, et al. Approaches to the assessment of cardiovascular risk in young adults. Profilakticheskaya Meditsina 2011; 5: 7-11. In Russian (Евсеева М. Е., Джанибекова А. Р., Еремин М. В. и др. Подходы к оценке сердечно-сосудистого риска у лиц молодого возраста. Профилактическая Медицина 2011;5:7-11).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Konstantinov VV, Deev AD, Balanova YA, et al. The risk profile of cardiovascular health and its contribution to the survival of men and women in Moscow aged 35-64. Profilakticheskaya Meditsina 2013; 1: 3-7. In Russian (Константинов В.В., Деев А.Д., Баланова Ю.А. и др. Профиль риска сердечнососудистого здоровья и его вклад в выживаемость у мужчин и женщин Москвы в возрасте 3564 лет. Профилактическая Медицина 2013;1:3-7).</mixed-citation><mixed-citation xml:lang="en">Konstantinov VV, Deev AD, Balanova YA, et al. The risk profile of cardiovascular health and its contribution to the survival of men and women in Moscow aged 35-64. Profilakticheskaya Meditsina 2013; 1: 3-7. In Russian (Константинов В.В., Деев А.Д., Баланова Ю.А. и др. Профиль риска сердечнососудистого здоровья и его вклад в выживаемость у мужчин и женщин Москвы в возрасте 3564 лет. Профилактическая Медицина 2013;1:3-7).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">National guidelines on cardiovascular prevention. Kardiovaskulyarnaya Terapiya i Profilaktika 2011; 10 (6) suppl 2: 1-22. In Russian (Национальные рекомендации по кардиоваскулярной профилактике. Кардиоваскулярная Терапия и Профилактика 2011; 10(6) Приложение 2:1-22).</mixed-citation><mixed-citation xml:lang="en">National guidelines on cardiovascular prevention. Kardiovaskulyarnaya Terapiya i Profilaktika 2011; 10 (6) suppl 2: 1-22. In Russian (Национальные рекомендации по кардиоваскулярной профилактике. Кардиоваскулярная Терапия и Профилактика 2011; 10(6) Приложение 2:1-22).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Cullen P., Rauterberg J., Lorkowski S. The Pathogenesis of Atherosclerosis. Handb Exp Pharmacol 2005;170:3-70.</mixed-citation><mixed-citation xml:lang="en">Cullen P., Rauterberg J., Lorkowski S. The Pathogenesis of Atherosclerosis. Handb Exp Pharmacol 2005;170:3-70.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Matsuura E., Atzeni F., Sarzi-Puttini P., et al. Is Atherosclerosis an autoimmune disease? BMC Med 2014;12:47.</mixed-citation><mixed-citation xml:lang="en">Matsuura E., Atzeni F., Sarzi-Puttini P., et al. Is Atherosclerosis an autoimmune disease? BMC Med 2014;12:47.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Mraz M., Haluzik M. The role of adipose tissue immune cells in obesity and low-grade inflammation. J Endocrinol 2014;222(3):R113-27.</mixed-citation><mixed-citation xml:lang="en">Mraz M., Haluzik M. The role of adipose tissue immune cells in obesity and low-grade inflammation. J Endocrinol 2014;222(3):R113-27.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Teryaeva NB. Adipokines: regulation of energy metabolism and the pathogenesis of cardiovascular disease. Kreativnaya Kardiologiya 2007; 1-2: 20-5. In Russian (Теряева Н.Б. Адипокины: регуляция энергетического метаболизма и патогенез сердечно-сосудистых заболеваний. Креативная Кардиология 2007;1-2: 20-5).</mixed-citation><mixed-citation xml:lang="en">Teryaeva NB. Adipokines: regulation of energy metabolism and the pathogenesis of cardiovascular disease. Kreativnaya Kardiologiya 2007; 1-2: 20-5. In Russian (Теряева Н.Б. Адипокины: регуляция энергетического метаболизма и патогенез сердечно-сосудистых заболеваний. Креативная Кардиология 2007;1-2: 20-5).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Proença A.R., Sertié R.A., Oliveira A.C., et al. New concepts in white adipose tissue physiology. Braz J Med Biol Res 2014;47(3):192-205.</mixed-citation><mixed-citation xml:lang="en">Proença A.R., Sertié R.A., Oliveira A.C., et al. New concepts in white adipose tissue physiology. Braz J Med Biol Res 2014;47(3):192-205.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Murdolo G., Smith U. The dysregulated adipose tissue: A connecting link between insulin resistance, type 2 diabetes mellitus and atherosclerosis. Nutrition, Metabolism &amp; Cardiovascular Diseases 2006;16:35-8.</mixed-citation><mixed-citation xml:lang="en">Murdolo G., Smith U. The dysregulated adipose tissue: A connecting link between insulin resistance, type 2 diabetes mellitus and atherosclerosis. Nutrition, Metabolism &amp; Cardiovascular Diseases 2006;16:35-8.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Wolk R., Berger P., Lennon R.J., et al. Plasma leptin and prognosis in patients with established coronary atherosclerosis. J Am CollCardiol 2004;44:1819-24.</mixed-citation><mixed-citation xml:lang="en">Wolk R., Berger P., Lennon R.J., et al. Plasma leptin and prognosis in patients with established coronary atherosclerosis. J Am CollCardiol 2004;44:1819-24.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Hao G, Li W., Guo R., et al. Serum total Adiponectin level and the risk of cardiovascular disease in general population: a meta-analysis of 17 prospective studies. Atherosclerosis 2013;228: 29-35.</mixed-citation><mixed-citation xml:lang="en">Hao G, Li W., Guo R., et al. Serum total Adiponectin level and the risk of cardiovascular disease in general population: a meta-analysis of 17 prospective studies. Atherosclerosis 2013;228: 29-35.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Kumada M., Kihara S., Sumitsuji S., et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003;23(1):85-9.</mixed-citation><mixed-citation xml:lang="en">Kumada M., Kihara S., Sumitsuji S., et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003;23(1):85-9.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Berg A.H., Combs T.P., Scherer P.E. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 2002;13(2):84-9.</mixed-citation><mixed-citation xml:lang="en">Berg A.H., Combs T.P., Scherer P.E. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 2002;13(2):84-9.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Mamaghani F., Zarghami N., Maleki M.J., et al. Variation of Adiponectin Levels in Normal and Obese subjects: Possible Correlation with Lipid Profiles. Int J Endocrinol Metab 2009;3:170-8.</mixed-citation><mixed-citation xml:lang="en">Mamaghani F., Zarghami N., Maleki M.J., et al. Variation of Adiponectin Levels in Normal and Obese subjects: Possible Correlation with Lipid Profiles. Int J Endocrinol Metab 2009;3:170-8.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Gorshkov IP, Zoloedov VI. Adipokines role in the pathogenesis of type 2 diabetes and metabolic syndrome. Vestnik Novykh Meditsinskikh Tekhnologiy 2010; (1): 132-4. In Russian (Горшков И.П., Золоедов В.И. Роль адипокинов в патогенезе сахарного диабета 2 типа и метаболического синдрома. Вестник Новых Медицинских Технологий 2010;(1):132-4).</mixed-citation><mixed-citation xml:lang="en">Gorshkov IP, Zoloedov VI. Adipokines role in the pathogenesis of type 2 diabetes and metabolic syndrome. Vestnik Novykh Meditsinskikh Tekhnologiy 2010; (1): 132-4. In Russian (Горшков И.П., Золоедов В.И. Роль адипокинов в патогенезе сахарного диабета 2 типа и метаболического синдрома. Вестник Новых Медицинских Технологий 2010;(1):132-4).</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Vega G.L., Grundy S.M. Metabolic risk susceptibility in men is partially related to adiponectin/leptin ratio. Journal of Obesity 2013;2013: 409679.</mixed-citation><mixed-citation xml:lang="en">Vega G.L., Grundy S.M. Metabolic risk susceptibility in men is partially related to adiponectin/leptin ratio. Journal of Obesity 2013;2013: 409679.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Bremer A.A., Jialal I. Adipose tissue dysfunction in nascent metabolic syndrome. Journal of Obesity 2013;2013: 393192.</mixed-citation><mixed-citation xml:lang="en">Bremer A.A., Jialal I. Adipose tissue dysfunction in nascent metabolic syndrome. Journal of Obesity 2013;2013: 393192.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Holland W.L., Miller R.A., Wang Z.V., et al. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat Med 2011;17(1):55-63.</mixed-citation><mixed-citation xml:lang="en">Holland W.L., Miller R.A., Wang Z.V., et al. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat Med 2011;17(1):55-63.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Roberts C.R., Sindhu K.K. Oxidative stress and metabolic syndrome. Life Sci 2009;84(21-22):705-12.</mixed-citation><mixed-citation xml:lang="en">Roberts C.R., Sindhu K.K. Oxidative stress and metabolic syndrome. Life Sci 2009;84(21-22):705-12.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Nakamura K., Fuster J.J., Walsh K. Adipokines: a link between obesity and cardiovascular disease. J Cardiol 2014;63(4):250-9.</mixed-citation><mixed-citation xml:lang="en">Nakamura K., Fuster J.J., Walsh K. Adipokines: a link between obesity and cardiovascular disease. J Cardiol 2014;63(4):250-9.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Yoon J.H., Kim S.K., Choi H.J., еt al. Adiponectin provides additional information to conventional cardiovascular risk factors for assessing the risk of atherosclerosis in both genders. PLoS One 2013;8(10):e75535.</mixed-citation><mixed-citation xml:lang="en">Yoon J.H., Kim S.K., Choi H.J., еt al. Adiponectin provides additional information to conventional cardiovascular risk factors for assessing the risk of atherosclerosis in both genders. PLoS One 2013;8(10):e75535.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Miyazaki T., Hiki M., Shimada K., et al. The high molecular weight adiponectin level is associated with the atherogenic lipoprotein profiles in healthy Japanese males. J Atheroscler Thromb 2014;21(7): 672-9.</mixed-citation><mixed-citation xml:lang="en">Miyazaki T., Hiki M., Shimada K., et al. The high molecular weight adiponectin level is associated with the atherogenic lipoprotein profiles in healthy Japanese males. J Atheroscler Thromb 2014;21(7): 672-9.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Liao H., Li Z., Zheng D., et al. Increased Hs-CRP/adiponectin ratio is associated with increase carotid intima-media thickness. Lipids Health Dis 2014;13:120.</mixed-citation><mixed-citation xml:lang="en">Liao H., Li Z., Zheng D., et al. Increased Hs-CRP/adiponectin ratio is associated with increase carotid intima-media thickness. Lipids Health Dis 2014;13:120.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Matsuda M., Tamura R., Kishida N., et al. Predictive value of adiponectin in patients with multivessel coronary atherosclerosis detected on computed tomography angiography. J Atheroscler Thromb 2013;20(10):767-76.</mixed-citation><mixed-citation xml:lang="en">Matsuda M., Tamura R., Kishida N., et al. Predictive value of adiponectin in patients with multivessel coronary atherosclerosis detected on computed tomography angiography. J Atheroscler Thromb 2013;20(10):767-76.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Kolasa-Trela R., Miszalski-Jamka T., Grudzień G., et al. Adiponectin, leptin, and resistin in patients with aortic stenosis without concomitant atherosclerotic vascular disease. Pol Arch Med Wewn 2011;121(10):352-59.</mixed-citation><mixed-citation xml:lang="en">Kolasa-Trela R., Miszalski-Jamka T., Grudzień G., et al. Adiponectin, leptin, and resistin in patients with aortic stenosis without concomitant atherosclerotic vascular disease. Pol Arch Med Wewn 2011;121(10):352-59.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Das K., Lin, Y., Widen E., et al. Chromosomal localization, expression pattern, and promoter analysis of the mouse gene encoding adipocyte-specific secretory protein Acrp30. Biochem Biophys Res Commun 2001;280(4):1120-9.</mixed-citation><mixed-citation xml:lang="en">Das K., Lin, Y., Widen E., et al. Chromosomal localization, expression pattern, and promoter analysis of the mouse gene encoding adipocyte-specific secretory protein Acrp30. Biochem Biophys Res Commun 2001;280(4):1120-9.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Maeda K., Okubo K., Shimomura I., et al. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (adipose most abundant gene transcript 1). Biochem Biophys Res Commun 1996; 221: 286-9.</mixed-citation><mixed-citation xml:lang="en">Maeda K., Okubo K., Shimomura I., et al. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (adipose most abundant gene transcript 1). Biochem Biophys Res Commun 1996; 221: 286-9.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Schaffler A., Orso E., Palitzsch K.D., et al. The human apM-1, an adipocyte-specific gene linked to the family of TNF's and to genes expressed in activated T cells, is mapped to chromosome 1q21.3-q23, a susceptibility locus identified for familial combined hyperlipidaemia (FCH). Biochem Biophys Res Commun 1999; 260: 416-425.</mixed-citation><mixed-citation xml:lang="en">Schaffler A., Orso E., Palitzsch K.D., et al. The human apM-1, an adipocyte-specific gene linked to the family of TNF's and to genes expressed in activated T cells, is mapped to chromosome 1q21.3-q23, a susceptibility locus identified for familial combined hyperlipidaemia (FCH). Biochem Biophys Res Commun 1999; 260: 416-425.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Saito K., Tobe T., Minoshima S., et al. Organization of the gene for gelatin-binding protein (GBP28) Gene1999;229:67-73.</mixed-citation><mixed-citation xml:lang="en">Saito K., Tobe T., Minoshima S., et al. Organization of the gene for gelatin-binding protein (GBP28) Gene1999;229:67-73.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Mtiraoui N., Ezzidi I., Turki A., et al. Single-nucleotide polymorphisms and haplotypes in the adiponectin gene contribute to the genetic risk for type 2 diabetes in Tunisian Arabs. Diabetes Res Clin Pract 2012;97(2):290-7.</mixed-citation><mixed-citation xml:lang="en">Mtiraoui N., Ezzidi I., Turki A., et al. Single-nucleotide polymorphisms and haplotypes in the adiponectin gene contribute to the genetic risk for type 2 diabetes in Tunisian Arabs. Diabetes Res Clin Pract 2012;97(2):290-7.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Ramya K., Ayyappa K.A., Ghosh S., et al. Genetic association of ADIPOQ gene variants with type 2 diabetes, obesity and serum adiponectin levels in south Indian population. Gene 2013; 532(2): 253-62.</mixed-citation><mixed-citation xml:lang="en">Ramya K., Ayyappa K.A., Ghosh S., et al. Genetic association of ADIPOQ gene variants with type 2 diabetes, obesity and serum adiponectin levels in south Indian population. Gene 2013; 532(2): 253-62.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Wassel C.L., Pankow J.S., Rasmussen-Torvik L.J., et al. Associations of SNPs in ADIPOQ and subclinical cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis (MESA). Obesity (Silver Spring) 2011;19(4):840-7.</mixed-citation><mixed-citation xml:lang="en">Wassel C.L., Pankow J.S., Rasmussen-Torvik L.J., et al. Associations of SNPs in ADIPOQ and subclinical cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis (MESA). Obesity (Silver Spring) 2011;19(4):840-7.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang F., Chen Y., Heiman M., DiMarchi R. Leptin: Structure, Function and Biology. Vitamins &amp; Hormones 2005;71:345-72.</mixed-citation><mixed-citation xml:lang="en">Zhang F., Chen Y., Heiman M., DiMarchi R. Leptin: Structure, Function and Biology. Vitamins &amp; Hormones 2005;71:345-72.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Farooqi I.S., O'Rahilly S. 20 years of leptin: human disorders of leptin action. J Endocrinol 2014;223(1):63-70.</mixed-citation><mixed-citation xml:lang="en">Farooqi I.S., O'Rahilly S. 20 years of leptin: human disorders of leptin action. J Endocrinol 2014;223(1):63-70.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Kolaczynski J.W., Nyce M.R., Considine R.V., et al. Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro. Diabetes 1996;45(5):699-701.</mixed-citation><mixed-citation xml:lang="en">Kolaczynski J.W., Nyce M.R., Considine R.V., et al. Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro. Diabetes 1996;45(5):699-701.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Vega G.L., Grundy S.M. Metabolic risk susceptibility in men is partially related to adiponectin/leptin ratio. Journal of Obesity 2013;2013: 409679.</mixed-citation><mixed-citation xml:lang="en">Vega G.L., Grundy S.M. Metabolic risk susceptibility in men is partially related to adiponectin/leptin ratio. Journal of Obesity 2013;2013: 409679.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Mohamed-Ali V., Pinkney J.H., Panahloo A., et al. Relationships Between Plasma Leptin and Insulin Concentrations, but not Insulin Resistance, in non-insulindependent (Type 2) Diabetes Mellitus. Diabet Med 1997;14(5):376-80.</mixed-citation><mixed-citation xml:lang="en">Mohamed-Ali V., Pinkney J.H., Panahloo A., et al. Relationships Between Plasma Leptin and Insulin Concentrations, but not Insulin Resistance, in non-insulindependent (Type 2) Diabetes Mellitus. Diabet Med 1997;14(5):376-80.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Khafaji H.A., Bener A.B., Rizk N.M., A.I. Suwaidi J. Elevated serum leptin levels in patients with acute myocardial infarction; correlation with coronary angiographic and echocardiographic findings. BMC Res Notes 2012;5:262.</mixed-citation><mixed-citation xml:lang="en">Khafaji H.A., Bener A.B., Rizk N.M., A.I. Suwaidi J. Elevated serum leptin levels in patients with acute myocardial infarction; correlation with coronary angiographic and echocardiographic findings. BMC Res Notes 2012;5:262.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Tsiotra P.C., Boutati E., Dimitriadis G., Raptis S.A. High insulin and leptin increase resistin and inflammatory cytokine production from human mononuclear cells. Biomed Res Int 2013;2013:487081.</mixed-citation><mixed-citation xml:lang="en">Tsiotra P.C., Boutati E., Dimitriadis G., Raptis S.A. High insulin and leptin increase resistin and inflammatory cytokine production from human mononuclear cells. Biomed Res Int 2013;2013:487081.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Schneiderman J., Schaefer K., Kolodgie F.D., et al. Leptin locally synthesized in carotid atherosclerotic plaques could be associated with lesion instability and cerebral emboli. J Am Heart Assoc 2012;1(5):e001727.</mixed-citation><mixed-citation xml:lang="en">Schneiderman J., Schaefer K., Kolodgie F.D., et al. Leptin locally synthesized in carotid atherosclerotic plaques could be associated with lesion instability and cerebral emboli. J Am Heart Assoc 2012;1(5):e001727.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Masuzaki H., Ogawa Y., Isse N., et al. Human obese gene expression: adipocyte-specific expression and regional differences in the adipose tissue. Diabetes 1995;44:855-8.</mixed-citation><mixed-citation xml:lang="en">Masuzaki H., Ogawa Y., Isse N., et al. Human obese gene expression: adipocyte-specific expression and regional differences in the adipose tissue. Diabetes 1995;44:855-8.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Ogawa Y., Masuzaki H., Isse N., et al. Molecular cloning of rat obese cDNA and augmented gene expression in genetically obese Zucker fatty (fa/fa) rats. J Clin Invest 1995;96:1647-52.</mixed-citation><mixed-citation xml:lang="en">Ogawa Y., Masuzaki H., Isse N., et al. Molecular cloning of rat obese cDNA and augmented gene expression in genetically obese Zucker fatty (fa/fa) rats. J Clin Invest 1995;96:1647-52.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Bevan S., Meidtner K., Lorenz M., et al. Adiponectin level as a consequence of genetic variation, but not leptin level or leptin: adiponectin ratio, is a risk factor for carotid intima-media thickness. Stroke 2011;42(6):1510-4.</mixed-citation><mixed-citation xml:lang="en">Bevan S., Meidtner K., Lorenz M., et al. Adiponectin level as a consequence of genetic variation, but not leptin level or leptin: adiponectin ratio, is a risk factor for carotid intima-media thickness. Stroke 2011;42(6):1510-4.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Shen J., Ge W., Zhang J., et al. Leptin -2548g/a Gene Polymorphism in Association with Antipsychotic-Induced Weight Gain: a Meta-Analysis Study. Psychiatr Danub 2014;26(2):145-51.</mixed-citation><mixed-citation xml:lang="en">Shen J., Ge W., Zhang J., et al. Leptin -2548g/a Gene Polymorphism in Association with Antipsychotic-Induced Weight Gain: a Meta-Analysis Study. Psychiatr Danub 2014;26(2):145-51.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Ng Z.Y., Veerapen M.K., Hon W.M., Lim R.L. Association of leptin/receptor and TNF-α gene variants with adolescent obesity in Malaysia. Pediatr Int 2014;56(5):689-97.</mixed-citation><mixed-citation xml:lang="en">Ng Z.Y., Veerapen M.K., Hon W.M., Lim R.L. Association of leptin/receptor and TNF-α gene variants with adolescent obesity in Malaysia. Pediatr Int 2014;56(5):689-97.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Weiss M., Donald F., Steiner M.D., et al. Biosynthesis, Secretion, Structure, and Structure-Activity Relationships. Endotext [Internet] 2000-2009.</mixed-citation><mixed-citation xml:lang="en">Weiss M., Donald F., Steiner M.D., et al. Biosynthesis, Secretion, Structure, and Structure-Activity Relationships. Endotext [Internet] 2000-2009.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Sonksen P., Sonksen J. Insulin: understanding its action in health and disease. British Journal of Anaesthesia 2000;85(1):69-79.</mixed-citation><mixed-citation xml:lang="en">Sonksen P., Sonksen J. Insulin: understanding its action in health and disease. British Journal of Anaesthesia 2000;85(1):69-79.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Girard J. Insulin's effect on the liver: "direct or indirect?" continues to be the question. J Clin Invest 2006;116(2):302-4.</mixed-citation><mixed-citation xml:lang="en">Girard J. Insulin's effect on the liver: "direct or indirect?" continues to be the question. J Clin Invest 2006;116(2):302-4.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Carmena R., Duriez P., Fruchart J. C. Atherogenic lipoprotein particles in atherosclerosis. Circulation 2004;109(23 Suppl 1):III 2-7.</mixed-citation><mixed-citation xml:lang="en">Carmena R., Duriez P., Fruchart J. C. Atherogenic lipoprotein particles in atherosclerosis. Circulation 2004;109(23 Suppl 1):III 2-7.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Monnier L., Hanefeld M., Schnell O., et al. / Insulin and atherosclerosis: how are they related? Diabetes Metab 2013;39(2):111-7.</mixed-citation><mixed-citation xml:lang="en">Monnier L., Hanefeld M., Schnell O., et al. / Insulin and atherosclerosis: how are they related? Diabetes Metab 2013;39(2):111-7.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Huerre C., Gilgenkrantz S., Leonard C., et al. Regional assignment of the structural gene for insulin to 11p15.1-11p15.5 by deletion mapping. (Abstract). Cytogenet Cell Genet 1984;37:495.</mixed-citation><mixed-citation xml:lang="en">Huerre C., Gilgenkrantz S., Leonard C., et al. Regional assignment of the structural gene for insulin to 11p15.1-11p15.5 by deletion mapping. (Abstract). Cytogenet Cell Genet 1984;37:495.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Steiner D. F., Chan S. J., Welsh J. M., Kwok S. C. M. Structure and evolution of the insulin gene. Annu Rev Genet 1985;19:463-84.</mixed-citation><mixed-citation xml:lang="en">Steiner D. F., Chan S. J., Welsh J. M., Kwok S. C. M. Structure and evolution of the insulin gene. Annu Rev Genet 1985;19:463-84.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Steiner D. F., Oyer P. E. The biosynthesis of insulin and a probable precursor of insulin by a human islet cell adenoma. Proc Nat Acad Sci 1967;57:473-80.</mixed-citation><mixed-citation xml:lang="en">Steiner D. F., Oyer P. E. The biosynthesis of insulin and a probable precursor of insulin by a human islet cell adenoma. Proc Nat Acad Sci 1967;57:473-80.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
